HEADER HYDROLASE/HYDROLASE INHIBITOR 28-JUL-10 3O56 TITLE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A 5- TITLE 2 HETEROCYCLE PYRAZOLOPYRIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 324-675; COMPND 5 SYNONYM: DPDE4, PDE32; COMPND 6 EC: 3.1.4.17; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDE4B, DPDE4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PDE, HYDROLASE, PHOSPHODIESTERASE, CAMP BINDING, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.O.SOMERS,M.NEU REVDAT 2 06-SEP-23 3O56 1 REMARK SEQADV LINK REVDAT 1 03-AUG-11 3O56 0 JRNL AUTH C.J.MITCHELL,S.P.BALLANTINE,D.M.COE,C.M.COOK,C.J.DELVES, JRNL AUTH 2 M.D.DOWLE,C.D.EDLIN,J.N.HAMBLIN,S.HOLMAN,M.R.JOHNSON, JRNL AUTH 3 P.S.JONES,S.E.KEELING,M.KRANZ,M.LINDVALL,F.S.LUCAS,M.NEU, JRNL AUTH 4 Y.E.SOLANKE,D.O.SOMERS,N.A.TRIVEDI,J.O.WISEMAN JRNL TITL PYRAZOLOPYRIDINES AS POTENT PDE4B INHIBITORS: 5-HETEROCYCLE JRNL TITL 2 SAR. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 5803 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20732811 JRNL DOI 10.1016/J.BMCL.2010.07.136 REMARK 2 REMARK 2 RESOLUTION. 2.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 17097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 865 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.42 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.48 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1165 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE SET COUNT : 66 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2705 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 124 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.19000 REMARK 3 B22 (A**2) : -3.21000 REMARK 3 B33 (A**2) : 9.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.270 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.211 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.207 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2821 ; 0.014 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1849 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3825 ; 1.325 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4528 ; 0.905 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 336 ; 4.937 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 140 ;37.595 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 491 ;16.163 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;15.043 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 428 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3110 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 544 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1677 ; 1.741 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 671 ; 0.464 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2719 ; 3.066 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1144 ; 3.722 ; 5.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1105 ; 5.611 ; 7.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 3O56 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1000060678. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9393 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.1.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17117 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.420 REMARK 200 RESOLUTION RANGE LOW (A) : 29.703 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : 0.09400 REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.37900 REMARK 200 R SYM FOR SHELL (I) : 0.37900 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 3D3P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14-18% PEG 3000, 10% GLYCEROL, 50MM REMARK 280 SODIUM CACODYLATE PH 6.5, 100MM SODIUM ACETATE, 1M SODIUM REMARK 280 CHLORIDE, 1% DMF, 5MM DTT, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.26550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.54450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.29600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.54450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.26550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.29600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.26550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.29600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 52.54450 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.29600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.26550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 52.54450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 151 REMARK 465 SER A 152 REMARK 465 PRO A 488 REMARK 465 ALA A 489 REMARK 465 PRO A 490 REMARK 465 PRO A 491 REMARK 465 LEU A 492 REMARK 465 ASP A 493 REMARK 465 GLU A 494 REMARK 465 GLN A 495 REMARK 465 ASN A 496 REMARK 465 ARG A 497 REMARK 465 ASP A 498 REMARK 465 CYS A 499 REMARK 465 GLN A 500 REMARK 465 GLY A 501 REMARK 465 LEU A 502 REMARK 465 MET A 503 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 320 AS ARS A 2 1.79 REMARK 500 SG CYS A 432 AS ARS A 3 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 392 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 392 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 368 -57.04 -26.58 REMARK 500 LEU A 393 43.23 -93.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 1 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 51 O REMARK 620 2 HIS A 238 NE2 163.1 REMARK 620 3 HIS A 274 NE2 86.0 110.8 REMARK 620 4 ASP A 275 OD2 82.2 95.8 88.2 REMARK 620 5 ASP A 392 OD1 96.7 86.9 86.1 174.2 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 504 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 49 O REMARK 620 2 HOH A 50 O 99.9 REMARK 620 3 HOH A 51 O 163.7 95.8 REMARK 620 4 HOH A 52 O 95.6 86.9 81.0 REMARK 620 5 HOH A 53 O 92.3 91.7 91.4 172.1 REMARK 620 6 ASP A 275 OD1 87.7 166.3 76.1 81.1 99.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZG1 A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 507 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D3P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PDE4B CATALYTIC DOMAIN IN COMPLEX WITH A REMARK 900 PYRAZOLOPYRIDINE INHIBITOR REMARK 900 RELATED ID: 3O57 RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A REMARK 900 5-HETEROCYCLE PYRAZOLOPYRIDINE INHIBITOR DBREF 3O56 A 152 503 UNP Q07343 PDE4B_HUMAN 324 675 SEQADV 3O56 MET A 151 UNP Q07343 INITIATING METHIONINE SEQADV 3O56 ALA A 482 UNP Q07343 SER 654 ENGINEERED MUTATION SEQADV 3O56 ALA A 487 UNP Q07343 SER 659 ENGINEERED MUTATION SEQADV 3O56 ALA A 489 UNP Q07343 SER 661 ENGINEERED MUTATION SEQRES 1 A 353 MET SER ILE SER ARG PHE GLY VAL ASN THR GLU ASN GLU SEQRES 2 A 353 ASP HIS LEU ALA LYS GLU LEU GLU ASP LEU ASN LYS TRP SEQRES 3 A 353 GLY LEU ASN ILE PHE ASN VAL ALA GLY TYR SER HIS ASN SEQRES 4 A 353 ARG PRO LEU THR CYS ILE MET TYR ALA ILE PHE GLN GLU SEQRES 5 A 353 ARG ASP LEU LEU LYS THR PHE ARG ILE SER SER ASP THR SEQRES 6 A 353 PHE ILE THR TYR MET MET THR LEU GLU ASP HIS TYR HIS SEQRES 7 A 353 SER ASP VAL ALA TYR HIS ASN SER LEU HIS ALA ALA ASP SEQRES 8 A 353 VAL ALA GLN SER THR HIS VAL LEU LEU SER THR PRO ALA SEQRES 9 A 353 LEU ASP ALA VAL PHE THR ASP LEU GLU ILE LEU ALA ALA SEQRES 10 A 353 ILE PHE ALA ALA ALA ILE HIS ASP VAL ASP HIS PRO GLY SEQRES 11 A 353 VAL SER ASN GLN PHE LEU ILE ASN THR ASN SER GLU LEU SEQRES 12 A 353 ALA LEU MET TYR ASN ASP GLU SER VAL LEU GLU ASN HIS SEQRES 13 A 353 HIS LEU ALA VAL GLY PHE LYS LEU LEU GLN GLU GLU HIS SEQRES 14 A 353 CYS ASP ILE PHE MET ASN LEU THR LYS LYS GLN ARG GLN SEQRES 15 A 353 THR LEU ARG LYS MET VAL ILE ASP MET VAL LEU ALA THR SEQRES 16 A 353 ASP MET SER LYS HIS MET SER LEU LEU ALA ASP LEU LYS SEQRES 17 A 353 THR MET VAL GLU THR LYS LYS VAL THR SER SER GLY VAL SEQRES 18 A 353 LEU LEU LEU ASP ASN TYR THR ASP ARG ILE GLN VAL LEU SEQRES 19 A 353 ARG ASN MET VAL HIS CYS ALA ASP LEU SER ASN PRO THR SEQRES 20 A 353 LYS SER LEU GLU LEU TYR ARG GLN TRP THR ASP ARG ILE SEQRES 21 A 353 MET GLU GLU PHE PHE GLN GLN GLY ASP LYS GLU ARG GLU SEQRES 22 A 353 ARG GLY MET GLU ILE SER PRO MET CYS ASP LYS HIS THR SEQRES 23 A 353 ALA SER VAL GLU LYS SER GLN VAL GLY PHE ILE ASP TYR SEQRES 24 A 353 ILE VAL HIS PRO LEU TRP GLU THR TRP ALA ASP LEU VAL SEQRES 25 A 353 GLN PRO ASP ALA GLN ASP ILE LEU ASP THR LEU GLU ASP SEQRES 26 A 353 ASN ARG ASN TRP TYR GLN ALA MET ILE PRO GLN ALA PRO SEQRES 27 A 353 ALA PRO PRO LEU ASP GLU GLN ASN ARG ASP CYS GLN GLY SEQRES 28 A 353 LEU MET HET ZN A 1 1 HET MG A 504 1 HET ARS A 505 2 HET ARS A 2 1 HET ARS A 3 1 HET ZG1 A 506 39 HET GOL A 507 6 HET GOL A 508 6 HETNAM ZN ZINC ION HETNAM MG MAGNESIUM ION HETNAM ARS ARSENIC HETNAM ZG1 1-ETHYL-5-[3-(2-OXO-2-PYRROLIDIN-1-YLETHYL)-1,2,4- HETNAM 2 ZG1 OXADIAZOL-5-YL]-N-(TETRAHYDRO-2H-PYRAN-4-YL)-1H- HETNAM 3 ZG1 PYRAZOLO[3,4-B]PYRIDIN-4-AMINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN ZN 2+ FORMUL 3 MG MG 2+ FORMUL 4 ARS 3(AS) FORMUL 7 ZG1 C21 H27 N7 O3 FORMUL 8 GOL 2(C3 H8 O3) FORMUL 10 HOH *124(H2 O) HELIX 1 1 ASN A 159 GLU A 171 1 13 HELIX 2 2 ASN A 179 SER A 187 1 9 HELIX 3 3 ARG A 190 ARG A 203 1 14 HELIX 4 4 ASP A 204 PHE A 209 1 6 HELIX 5 5 SER A 212 HIS A 226 1 15 HELIX 6 6 ASN A 235 SER A 251 1 17 HELIX 7 7 THR A 252 ASP A 256 5 5 HELIX 8 8 THR A 260 HIS A 274 1 15 HELIX 9 9 SER A 282 THR A 289 1 8 HELIX 10 10 SER A 291 ASN A 298 1 8 HELIX 11 11 SER A 301 LEU A 314 1 14 HELIX 12 12 THR A 327 ALA A 344 1 18 HELIX 13 13 THR A 345 SER A 348 5 4 HELIX 14 14 LYS A 349 GLU A 362 1 14 HELIX 15 15 ASN A 376 LEU A 393 1 18 HELIX 16 16 SER A 394 LYS A 398 5 5 HELIX 17 17 SER A 399 ARG A 424 1 26 HELIX 18 18 SER A 429 ASP A 433 5 5 HELIX 19 19 SER A 438 ILE A 450 1 13 HELIX 20 20 ILE A 450 VAL A 462 1 13 HELIX 21 21 ALA A 466 ALA A 482 1 17 LINK ZN ZN A 1 O HOH A 51 1555 1555 2.10 LINK ZN ZN A 1 NE2 HIS A 238 1555 1555 2.10 LINK ZN ZN A 1 NE2 HIS A 274 1555 1555 2.28 LINK ZN ZN A 1 OD2 ASP A 275 1555 1555 1.94 LINK ZN ZN A 1 OD1 ASP A 392 1555 1555 1.99 LINK O HOH A 49 MG MG A 504 1555 1555 2.17 LINK O HOH A 50 MG MG A 504 1555 1555 2.24 LINK O HOH A 51 MG MG A 504 1555 1555 2.30 LINK O HOH A 52 MG MG A 504 1555 1555 2.16 LINK O HOH A 53 MG MG A 504 1555 1555 1.98 LINK OD1 ASP A 275 MG MG A 504 1555 1555 2.14 CISPEP 1 GLN A 463 PRO A 464 0 1.59 SITE 1 AC1 6 HOH A 51 HOH A 81 HIS A 238 HIS A 274 SITE 2 AC1 6 ASP A 275 ASP A 392 SITE 1 AC2 6 HOH A 49 HOH A 50 HOH A 51 HOH A 52 SITE 2 AC2 6 HOH A 53 ASP A 275 SITE 1 AC3 2 PHE A 156 CYS A 194 SITE 1 AC4 1 CYS A 320 SITE 1 AC5 3 HOH A 124 CYS A 432 ZG1 A 506 SITE 1 AC6 16 ARS A 3 HOH A 5 HOH A 122 HOH A 123 SITE 2 AC6 16 HOH A 124 TYR A 233 MET A 347 LEU A 393 SITE 3 AC6 16 ASN A 395 THR A 407 ILE A 410 PHE A 414 SITE 4 AC6 16 MET A 431 CYS A 432 GLN A 443 PHE A 446 SITE 1 AC7 6 HOH A 110 ARG A 210 ALA A 257 VAL A 258 SITE 2 AC7 6 PHE A 259 THR A 260 CRYST1 88.531 94.592 105.089 90.00 90.00 90.00 I 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011296 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010572 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009516 0.00000